List Title | APhA DrugInfoLine

Infectious Diseases

SORT BY: Most Recent Most Viewed

July 1, 2000

Antibiotic Resistance: Focusing on Patients, Pharmacists

READ

PREVIEW
As clinicians struggle to maintain effectiveness of antibiotics for serious pathogens, a variety of social, cultural, and economic factors are compromising care. Two recently published articles...
June 1, 2000

Linezolid Adds Important Agent for Difficult-to-Treat Infections

READ

PREVIEW
The first agent in a completely new class of antibiotics—linezolid (Zyvox—Pharmacia)— is indicated for treatment of problematic gram-positive pathogens. The antibiotic, with...
April 1, 2000

Penicillin V for Treatment of Strep Throat: Using an Old Drug in a New Way

READ

PREVIEW
New information is leading clinicians to experiment with shorter courses and fewer daily doses of penicillin V in the treatment of group A beta-hemolytic streptococci (GAHBS) pharyngitis. While...
February 1, 2000

Short Supplies, Poor Taste Not Stopping Use of New Flu Drugs

READ

PREVIEW
January’s flu epidemic produced spot shortages of the new, broad-spectrum neuraminidase inhibitors, but many patients could have been treated with older, less expensive agents that are...
January 1, 2000

Oral Antibiotics for Low-Risk Chemotherapy Patients

READ

PREVIEW
Hospitalized neutropenic patients at low risk for complications can be effectively treated during febrile episodes with oral agents, avoiding the expense of intravenous therapy.

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.